• Home
  • Sitemap
  • Help
  • Technical Support
  • Contact
Cytoskeleton & Extracellular Matrix Other Products
You are here: Product Lines > Cytoskeleton > Cytoskeleton & Extracellular Matrix Other Products
Toolbar - View Selection
 
Items 9 of 9
ALX-201-246 Revised 24-Apr-08
Matriptase (human) (recombinant)
Add to Clipboard
SYNONYMS MT-SP1 (human) (recombinant)
Membrane-type Serine Protease 1 (human) (recombinant)
ST14 (human) (recombinant)
Suppression of Tumorigenicity Protein 14 (human) (recombinant)
TADG-15 (human) (recombinant)
Tumor-associated Differentially Expressed Gene 15 Protein (human) (recombinant)
SNC19 (human) (recombinant)
PRODUCT LINE Signal Transduction
PRODUCT CATEGORY Proteases Other Products
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-201-246-U125   125 U 360.00 USD Add To Cart
Product Specification
MW: ~25kDa
SOURCE/HOST: Recombinant human matriptase (aa 596-855) fused at the N-terminus to a His-tag.
CONCENTRATION: 100nM
PURITY: ≥98% (SDS-PAGE)
FORMULATION: Liquid. In 100mM TRIS, pH 9.0, containing 200mM sodium chloride, 1mM β-mercaptoethanol and 10% glycerol.
ACTIVITY: Trypsin-like serine protease.
SPECIFIC ACTIVITY: ~2.5U/µl. One unit is defined as the amount of enzyme that releases 1nmol of AMC per min. at 37°C in the presence of 50µM of Boc-Gln-Ala-Arg-AMC.
SHIPPING: SHIPPED ON DRY ICE
SHORT TERM STORAGE: -20°C
LONG TERM STORAGE: -80°C
USE/STABILITY: Stable for at least 6 months when stored at -20°C. Do not store diluted solutions.
HANDLING: Avoid freeze/thaw cycles.
Product Specific Literature References
Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue: T. Takeuchi, et al.; PNAS 96, 11054 (1999) Abstract; Full Text
Inhibition of human matriptase by eglin c variants: A. Désilets, et al.; FEBS Lett. 580, 2227 (2006) Abstract
General Information
BACKGROUND/TECHNICAL INFORMATION Recommended Assay Buffer:
100mM TRIS, pH 9.5, containing 5mg/ml BSA.
Further Categories Containing This Product:
Cancer Other Products • Cytoskeleton & Extracellular Matrix Other Products • Recombinant Proteins / Fusion Proteins
 
 
ALX-803-314 Revised 10-Apr-08
Monoclonal Antibody to COMP (484D1)
Add to Clipboard
SYNONYMS anti-Cartilage Oligomeric Matrix Protein MAb (484D1)
PRODUCT LINE Cytoskeleton
PRODUCT CATEGORY Cytoskeleton & Extracellular Matrix Other Products
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-803-314-R100   100 µl 310.00 USD Add To Cart
Product Specification
SPECIES CROSSREACTIVITY:
Human
Rat
Others
CLONE: 484D1
ISOTYPE: Rat IgG1
FORMULATION: Liquid. Ascites.
IMMUNOGEN: Human COMP (cartilage oligomeric matrix protein).
SPECIFICITY: Recognizes human, rat and bovine COMP.
APPLICATION: ELISA (1:500-1:2'000)
Immunohistochemistry (frozen sections (1:100-1:300))
Immunoprecipitation (1:100-1:300)
Western Blot (1:100-1:1'000)
SHIPPING: SHIPPED ON BLUE ICE
SHORT TERM STORAGE: +4°C
LONG TERM STORAGE: -20°C
HANDLING: Avoid freeze/thaw cycles.
Product Specific Literature References
Expression of cartilage oligomeric matrix protein (COMP) by embryonic and adult osteoblasts: P.E. Di Cesare, et al.; J. Orthop. Res. 18, 713 (2000) Abstract
Matrix-matrix interaction of cartilage oligomeric matrix protein and fibronectin: P.E. Di Cesare, et al.; Matrix Biol. 21, 461 (2002) Abstract
General Information
COMP (cartilage oligomeric matrix protein is a tissue-specific non-collagenous protein that was shown to be an important biomarker for inflammatory diseases. Mutations in the gene encoding COMP cause two common skeletal dysplasias, pseudoachondroplasia (PSACH) and mutiple epiphyseal dysplasia (MED).
General Literature References
Characterization of human and mouse cartilage oligomeric matrix protein: G. Newton, et al.; Genomics 24, 435 (1994) Abstract
Cartilage oligomeric matrix protein level in rheumatic diseases: potential use as a marker for measuring articular cartilage damage and/or the therapeutic efficacy of treatments: G. Morozzi, et al.; Ann. N.Y. Acad. Sci. 1108, 398 (2007) Abstract
Further Categories Containing This Product:
Inflammation Other Products • Bone Metabolism Other Products • Monoclonal Antibodies
 
 
ALX-804-622 Revised 23-Apr-08
Monoclonal Antibody to Fibulin-1 (human) (MEM-2)
Add to Clipboard
SYNONYMS anti-Basement-membrane Protein 90 (human) MAb (MEM-2)
anti-BM-90 (human) MAb (MEM-2)
PRODUCT LINE Cytoskeleton
PRODUCT CATEGORY Cytoskeleton & Extracellular Matrix Other Products
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-804-622-C050   50 µg 210.00 USD Add To Cart
Product Specification
SPECIES CROSSREACTIVITY:
Human
CLONE: MEM-2
ISOTYPE: Mouse IgM
CONCENTRATION:

FORMULATION: Liquid. In 20mM TRIS, pH 7.4, containing 1.25M sodium chloride and 0.02% sodium azide.
IMMUNOGEN: Recombinant human fibulin-1.
SPECIFICITY: Recognizes human fibulin-1.
APPLICATION: Flow Cytometry
Immunohistochemistry (frozen sections; paraffin sections)
Immunoprecipitation
Western Blot
SHIPPING: SHIPPED ON BLUE ICE
LONG TERM STORAGE: +4°C
HANDLING: Do not freeze.
Product Specific Literature References
Monoclonal antibody to fibulin-1 generated by genetic immunization: S.M. Pupa, et al.; J. Cell. Biochem. 89, 647 (2003) Abstract
Immunological and pathobiological roles of fibulin-1 in breast cancer: S.M. Pupa, et al.; Oncogene 23, 2153 (2004) Abstract
General Information
The fibulins are a family of secreted glycoproteins that are components of elastic matrix fibers and basement membranes. Fibulin-1 is an extracellular matrix protein, which can adhere to endothelial cells and regulate their motility and proliferation. Fibulin-1 is overexpressed in estrogen receptor (ER)-positive ovarian carcinomas and several studies suggest a possible role for fibulin-1 as a tumor suppressor. Xie et al. described that fibulin-1 inhibits tumor growth in HT1080 cell lines by suppressing tumor angiogenesis and inducing apoptosis.
General Literature References
Basement membrane derived fibulin-1 and fibulin-5 function as angiogenesis inhibitors and suppress tumor growth: L. Xie, et al.; Exp. Biol. Med. (Maywood) 233, 155 (2008) Abstract
Further Categories Containing This Product:
Tumor Suppressors / Related Products • Monoclonal Antibodies
 
 
ALX-804-096 Revised 06-Jan-05
Monoclonal Antibody to β1 Spectrin (4C3)
Add to Clipboard
PRODUCT LINE Cytoskeleton
PRODUCT CATEGORY Cytoskeleton & Extracellular Matrix Other Products
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-804-096-R100   100 µl 379.00 USD Add To Cart
Product Specification
SPECIES CROSSREACTIVITY:
Human
Mouse
Rat
CLONE: 4C3
ISOTYPE: Mouse IgG1
FORMULATION: Contains 0.05% sodium azide.
IMMUNOGEN: Purified human erythrocyte β1 spectrin (β1 Sp).
SPECIFICITY: Recognizes alternatively spliced forms of β1 spectrin (β1ε1 and β1ε2) in human, mouse and rat tissues. Does not cross-react with α2 Sp or fodrin.
APPLICATION: Immunocytochemistry (1:25)
Western Blot (1:100)
SHIPPING: SHIPPED ON BLUE ICE
LONG TERM STORAGE: -20°C
Further Categories Containing This Product:
Monoclonal Antibodies
 
 
ALX-BC-3010-S Revised 26-Jan-05
Monoclonal Antibody to Titin (F146.9B9)
Add to Clipboard
PRODUCT LINE Cytoskeleton
PRODUCT CATEGORY Cytoskeleton & Extracellular Matrix Other Products
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-BC-3010-S-L001   1 ml 135.00 USD Add To Cart
ALX-BC-3010-S-L005   5 ml 460.00 USD Add To Cart
Product Specification
SPECIES CROSSREACTIVITY:
Human
Mouse
Others
CLONE: F146.9B9
ISOTYPE: Mouse IgG1
FORMULATION: 1ml/5ml of sterile filtered supernatant containing 0.1% sodium azide.
IMMUNOGEN: Purified titin from human skeletal muscle.
SPECIFICITY: Recognizes human, mouse and rabbit titin.
APPLICATION: Immunohistochemistry (frozen sections), Western Blot (dilution 1:10).
SHIPPING: SHIPPED ON BLUE ICE
LONG TERM STORAGE: -20°C
General Information
MANUFACTURER Manufactured by BioCytex.
Further Categories Containing This Product:
Monoclonal Antibodies
 
 
ALX-210-265 Revised 30-Oct-06
Polyclonal Antibody to Dia1
Add to Clipboard
PRODUCT LINE Cytoskeleton
PRODUCT CATEGORY Cytoskeleton & Extracellular Matrix Other Products
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-210-265-R100   100 µl 370.00 USD Add To Cart
Product Specification
SPECIES CROSSREACTIVITY:
Human
Pig
SOURCE/HOST: From rabbit.
FORMULATION: Liquid. Crude antiserum containing 0.01% sodium azide.
IMMUNOGEN: Human Dia1 isolated from human platelet lysates.
SPECIFICITY: Recognizes human and pig Dia1. Detects a band of ~81kDa by Western blot.
APPLICATION: Immunoprecipitation (1:100)
Western Blot (1:1’000-1:1’500)
Optimal conditions must be determined individually for each application.
SHIPPING: SHIPPED ON BLUE ICE
SHORT TERM STORAGE: +4°C
LONG TERM STORAGE: -20°C
HANDLING: Avoid freeze/thaw cycles.
POSITIVE CONTROL: Human skin fibroblast protein (100µg) (Prod. No. ALX-840-009), supplied at 1mg/ml in SDS sample buffer (100mM NaCl, 73mM TRIS/HCl pH 6.7, 10mM DTT, 8mM EDTA, 5% glycerol, 2% SDS, 10µg/ml Bromophenol Blue sodium salt).
Use 25µl (25µg) per lane for Western blotting of tricine gels (13% acrylamide) or 15% Laemmli gels.
Product Specific Literature References
The proline-rich focal adhesion and microfilament protein VASP is a ligand for profilins: M. Reinhard, et al.; EMBO J. 14, 1583 (1995) Abstract
General Information
Drosophila Diaphanous [1], its mouse homologue p140mDia [2] (mDia1), mDia2 [3], and the human homologues [4,5] Dia1 and 2 are members of the Formin homology (FH) family of cytoskeletal organizer proteins. Diaphanous proteins contain a Rho-binding domain close to their N-terminus followed by a proline-rich region (designated as FH1 domain) with several poly-proline stretches and a conserved FH2 domain in the middle and C-terminal parts of the protein, respectively [2,6,7].
Drosophila Diaphanous is involved in cytokinesis and mutated alleles affect spermatogenesis or oogenesis, respectively, and lead to sterility [1]. The gene encoding a human Diaphanous protein is disrupted in a patient with Premature Ovarian Failure (POF) [5]. Nonsyndromic Deafness DFNA1, an autosomal dominant fully penetrant progressive hearing loss, is associated with a mutation in the human gene for Dia 1 [4].
P140mDia binds profilin and GTP-Rho, and colocalizes with Rho and profilin in membrane lamellae of motile cells and phagocytic cups engulfing fibronectin-coated beads [2]. Diaphanous has been suggested to contribute to localized actin polymerization and stress fiber formation, both by recruiting profilin to sites of Rho action and by cooperating with ROCK [2, 8-10]. P140mDia was also found in association with the cleavage furrow of dividing cells indicating some function during contractile ring formation. Diaphanous proteins are required for cytokinesis, stress fiber formation, and transcriptional activation of the serum response factor (SRF) [3].
General Literature References
[1] Diaphanous is required for cytokinesis in Drosophila and shares domains of similarity with the products of the limb deformity gene: D.H. Castrillon and S.A. Wasserman; Development 120, 3367 (1994) Abstract
[2] p140mDia, a mammalian homolog of Drosophila diaphanous, is a target protein for Rho small GTPase and is a ligand for profilin: N. Watanabe, et al.; EMBO J. 16, 3044 (1997) Abstract; Full Text
[3] Diaphanous-related formins bridge Rho GTPase and Src tyrosine kinase signaling: T. Tominaga, et al.; Mol. Cell 5, 13 (2000) Abstract
[4] Nonsyndromic deafness DFNA1 associated with mutation of a human homolog of the Drosophila gene diaphanous: E.D. Lynch, et al.; Science 278, 1315 (1997) Abstract
[5] A human homologue of the Drosophila melanogaster diaphanous gene is disrupted in a patient with premature ovarian failure: evidence for conserved function in oogenesis and implications for human sterility: S. Bione, et al.; Am. J. Hum. Genet. 62, 533 (1998) Abstract; Full Text
[6] FH proteins as cytoskeletal organizers: S. Wasserman; TICB 8, 111 (1998), (Review) Abstract
[7] Rho effectors and reorganization of actin cytoskeleton: S. Narumiya, et al.; FEBS Lett. 410, 68 (1997), (Review) Abstract; Full Text
[8] Cooperation between mDia1 and ROCK in Rho-induced actin reorganization: N. Watanabe, et al.; Nat. Cell Biol. 1, 136 (1999) Abstract
[9] Distinct actions and cooperative roles of ROCK and mDia in Rho small G protein-induced reorganization of the actin cytoskeleton in Madin-Darby canine kidney cells: K. Nakano, et al.; Mol. Biol. Cell 10, 2481 (1999) Abstract; Full Text
[10] Stress fibres take shape: A.J. Ridley; Nat. Cell Biol. 1, E64 (1999) Abstract
Further Categories Containing This Product:
Polyclonal Antibodies
 
 
ALX-210-264 Revised 28-Sep-06
Polyclonal Antibody to Lipoma Preferred Partner
Add to Clipboard
SYNONYMS anti-LPP PAb
PRODUCT LINE Cytoskeleton
PRODUCT CATEGORY Cytoskeleton & Extracellular Matrix Other Products
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-210-264-C050   50 µg 465.00 USD Add To Cart
Product Specification
SPECIES CROSSREACTIVITY:
Human
Rat
Pig
SOURCE/HOST: From rabbit.
CONCENTRATION: 500µg/ml
PURITY DETAIL: Antigen-affinity purified after proteolytic cleavage and removal of GST-tag. Residual GST specific antibody activity is less than 5% of total activity (Western blot).
FORMULATION: Liquid. In PBS containing 0.01% sodium azide.
IMMUNOGEN: Recombinant human LPP (lipoma preferred partner) (aa 1-109).
SPECIFICITY: Recognizes human, rat and pig LPP.
APPLICATION: Immunocytochemistry (1:250-1:500)
Immunoprecipitation
Western Blot (1:1'000)
Optimal conditions must be determined individually for each application.
SHIPPING: SHIPPED ON BLUE ICE
SHORT TERM STORAGE: +4°C
LONG TERM STORAGE: -20°C
HANDLING: Avoid freeze/thaw cycles.
POSITIVE CONTROL: Human skin fibroblast protein (100µg) (Prod. No. ALX-840-009), supplied at 1mg/ml in SDS sample buffer (100mM NaCl, 73mM TRIS/HCl pH 6.7, 10mM DTT, 8mM EDTA, 5% glycerol, 2% SDS, 10µg/ml Bromophenol Blue sodium salt).
Use 25µl (25µg) per lane for Western blotting of tricine gels (13% acrylamide) or 15% Laemmli gels.
Product Images
Please click on thumbnails to enlarge.
General Information
Lipoma preferred partner (LPP) is encoded by the preferred fusion partner gene of the high mobility group protein HMGI-C [1]. LPP is frequently affected by chromosomal translocations in a major group of soft tissue lipomas [1], as well as in a parosteal lipoma [2] and in pulmonary chondroid hamartomas [3]. The resulting fusion proteins comprise three DNA binding domains of HMGI-C fused to two or three C-terminal LIM domains of LPP and a reciprocal prduct, respectively [1,3]. Expression of a HMGI-C/LPP fusion protein causes malignant transformation of fibroblasts [4].
Similar to its relatives zyxin [5] and TRIP6 (thyroid receptor interacting protein 6) [6]/ZRP-1 (zyxin related protein 1) [7], LPP consists of an N-terminal proline-rich domain followed by three C-terminal LIM domain (double zinc finger structures that are involved in protein-protein interactions) [1]. Like the cytoskeletal protein zyxin, LPP localizes to focal adhesions and cell-cell adherens junctions [8]. LPP harbors a nuclear export signal and displays transcriptional activation capacity [8].
General Literature References
[1] LPP, the preferred fusion partner gene of HMGIC in lipomas, is a novel member of the LIM protein gene family: M.M. Petit, et al.; Genomics 36, 118 (1996) Abstract
[2] Expression of reciprocal fusion transcripts of the HMGIC and LPP genes in parosteal lipoma: M.M. Petit, et al.; Cancer Genet. Cytogenet. 106, 18 (1998) Abstract
[3] The t(3;12)(q27;q14-q15) with underlying HMGIC-LPP fusion is not determining an adipocytic phenotype: P. Rogalla, et al.; Genes Chromosomes Cancer 22, 100 (1998) Abstract
[4] Truncated and chimeric HMGI-C genes induce neoplastic transformation of NIH3T3 murine fibroblasts: M. Fedele, et al.; Oncogene 17, 413 (1998) Abstract
[5] Zyxin: B.E. Drees & M.C. Beckerle; In: Guidebook to the extracellular matrix, anchor, and adhesion proteins. T. Kreis & R. Vale (Eds.), 2nd ed., Oxford University Press, New York (1999)
[6] Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor: J.W. Lee, et al.; Mol. Endocrinol. 9, 243 (1995) Abstract
[7] ZRP-1, a zyxin-related protein, interacts with the second PDZ domain of the cytosolic protein tyrosine phosphatase hPTP1E: K.K. Murthy, et al.; J. Biol. Chem. 274, 20679 (1999) Abstract; Full Text
[8] LPP, an actin cytoskeleton protein related to zyxin, harbors a nuclear export signal and transcriptional activation capacity: M.M. Petit, et al.; Mol. Biol. Cell. 11, 117 (2000) Abstract
Further Categories Containing This Product:
Polyclonal Antibodies
 
 
ALX-210-894 Revised 12-Sep-05
Polyclonal Antibody to Tenascin-W
Add to Clipboard
PRODUCT LINE Cytoskeleton
PRODUCT CATEGORY Cytoskeleton & Extracellular Matrix Other Products
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-210-894-C100   100 µg 320.00 USD Add To Cart
Product Specification
SPECIES CROSSREACTIVITY:
Human
Mouse
Rat
SOURCE/HOST: From rabbit.
CONCENTRATION: 1mg/ml
PURITY: ≥90%
PURITY DETAIL: Protein A-affinity purified.
FORMULATION: Liquid. In TRIS/glycine, pH 8.0, containing 0.01% sodium azide.
IMMUNOGEN: Recombinant FNIII repeats 7-9 of mouse tenascin-W.
SPECIFICITY: Recognizes human, mouse and rat tenascin-W.
APPLICATION: ELISA (1:10’000)
Immunocytochemistry (1:1’000)
Immunohistochemistry (frozen sections, paraffin sections (1:500))
Immunoprecipitation
Western Blot (1:1’000)
SHIPPING: SHIPPED ON BLUE ICE
SHORT TERM STORAGE: +4°C
LONG TERM STORAGE: -20°C
HANDLING: Avoid freeze/thaw cycles.
Product Specific Literature References
Murine tenascin-W: a novel mammalian tenascin expressed in kidney and at sites of bone and smooth muscle development: A. Scherberich, et al.; J. Cell Sci. 117, 571 (2004) Abstract; Full Text
Tenascin-W is found in malignant mammary tumors, promotes alpha8 integrin-dependent motility and requires p38MAPK activity for BMP-2 and TNF-alpha induced expression in vitro: A. Scherberich, et al.; Oncogene 24, 1525 (2005) Abstract
General Literature References
Tenascins: R. Chiquet-Ehrismann; Int. J. Biochem. Cell Biol. 36, 986 (2004) Abstract
Connective tissues: signalling by tenascins: R. Chiquet-Ehrismann and R.P. Tucker; Int. J. Biochem. Cell Biol. 36, 1085 (2004) Abstract
Further Categories Containing This Product:
Polyclonal Antibodies • Tumor Markers
 
 
ALX-630-100 Revised 23-Oct-08
Toxin A, from Clostridium difficile
Add to Clipboard
PRODUCT LINE Natural Products / Antibiotics
PRODUCT CATEGORY Other Toxins
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-630-100-C002   2 µg 170.00 USD Add To Cart
ALX-630-100-C100   100 µg 610.00 USD Add To Cart
Product Specification
MW: ~270kDa
SOURCE/HOST: Isolated from Clostridium difficile.
CONCENTRATION: 0.1mg/ml after reconstitution.
PURITY DETAIL: Migrates as two bands of >200kDa in SDS-PAGE.
FORMULATION: Lyophilized from 50mM TRIS, pH 7.5, containing 50mM sodium chloride and 0.1% trehalose.
RECONSTITUTION: Reconstitute with sterile distilled water.
ACTIVITY: Each lot is tested to confirm binding activity to fresh rabbit red blood cells using a hemagglutination assay. The lowest concentration producing a positive reaction was ~50µg/ml.
SHIPPING: AMBIENT
LONG TERM STORAGE: +4°C
USE/STABILITY: Activity was found to decrease to 1/10 after one week of storage at +4°C after reconstitution.
HANDLING: Do not freeze.
HAZARD: VERY TOXIC.
Product Description

Has potent cytotoxic and enterotoxic properties. Translocates to the cytosol of target cells and glucosylates small GTP-binding proteins such as Rho, Rac, and Cdc42. Induces actin condensation, cell death and opening of the tight junctions. Triggers release of pro-inflammatory cytokines from intestinal epithelial cells probably via activation of MAP kinases.
Product Specific Literature References
[1] A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding: M.M. Bradford; Anal. Biochem. 72, 248 (1976) Abstract
[2] Purification and characterization of Clostridium difficile toxin: R. D. Rolfe & S. M. Finegold; Infect. Immun. 257, 191 (1979) Abstract
[3] Clostridium difficile toxin A and its effects on cells: C. Fiorentini & M. Thelestam; Toxicon 297, 543 (1991) Abstract
[4] Effects of Clostridium difficile toxins on epithelial cell barrier: C. Pothoulakis; Ann. N. Y. Acad. Sci. 915, 347 (2000) Abstract
[5] Large clostridial cytotoxins: cellular biology of Rho/Ras-glucosylating toxins: J. Schirmer & K. Aktories; Biochim. Biophys. Acta 1673, 66 (2004) Abstract
[6] Clostridium difficile toxins: mechanism of action and role in disease: D. E. Voth & J. D. Ballard; Clin. Microbiol. Rev. 18, 247 (2005), (Review) Abstract
[7] Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function: T. Jank, et al.; Glycobiology 17, 15R (2007), (Review) Abstract
General Information
BACKGROUND/TECHNICAL INFORMATION Protein concentration is determined by the Bradford method [1] using BSA as a standard.
Further Categories Containing This Product:
Cytoskeleton & Extracellular Matrix Other Products
 
 
© 2008 ALEXIS Corporation, Privacy Policy, Disclaimer, Feedbackheader picture © micronaut.ch, another CS2 website